The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation
Pre-Survey

Before you view the tweetorial, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.

There is no fee to participate in this activity.

Question Title

* 1. Where are you in your career?

IBD Specialist

General GI

GI Surgeon

Fellow/Trainee

APP

PharmD

Other (please specify)

Question Title

* 2. Which section of the intestines demonstrates the greatest intestinal adaptation following bowel loss?

Duodenum

Ileum

Jejunum

Large intestine

Question Title

* 3. Which of the following is a potential complication of prolonged administration of parenteral nutrition?

Interstitial lung disease

Metabolic bone disease

Thrombocytopenia

Urolithiasis

Question Title

* 4. At this point, if reported by the patient, which of the following is most likely to represent an adverse effect of teduglutide?

Abdominal pain

Headache

Insomnia

Tremor

Question Title

* 5. How long after initiation of teduglutide should patients undergo a colonoscopy?

3 months

6 months

9 months

12 months

Question Title

* 6. A 9-year-old patient with SBS has been unable to wean from PN and had 3 admissions for CVL infections over the past year. Their stool output is 60mL/kg. Which of the following is the best next option for this patient to reduce PN dependence?

Cyproheptadine

Loperamide

Somatropin

Teduglutide

Question Title

* 7. A 13-year-old patient with short bowel syndrome was started on teduglutide 6 months ago due to inability to wean from parenteral nutrition (PN). They have since been able to decrease their PN volume by 50% and report no significant adverse events. Which of the following studies is indicated for this patient at this time?

Colonoscopy

C-reactive protein (CRP)

Lipase

Upper GI series

Question Title

* 8. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).
Please note that we will not forward or sell your contact information.

First and Last Name *

State/Province

ZIP/Postal Code *

Country

Email Address (required to receive credit) *

The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation***Pre-Survey***

Question Title

* 1. Where are you in your career?

Question Title

* 2. Which section of the intestines demonstrates the greatest intestinal adaptation following bowel loss?

Question Title

* 3. Which of the following is a potential complication of prolonged administration of parenteral nutrition?

Question Title

* 4. At this point, if reported by the patient, which of the following is most likely to represent an adverse effect of teduglutide?​

Question Title

* 5. How long after initiation of teduglutide should patients undergo a colonoscopy?

Question Title

* 6. A 9-year-old patient with SBS has been unable to wean from PN and had 3 admissions for CVL infections over the past year. Their stool output is 60mL/kg. Which of the following is the best next option for this patient to reduce PN dependence?

Question Title

Question Title

* 8. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).*Please note that we will not forward or sell your contact information.*

The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation
Pre-Survey

* 4. At this point, if reported by the patient, which of the following is most likely to represent an adverse effect of teduglutide?

* 8. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).
Please note that we will not forward or sell your contact information.